Focus: Globus Medical is a public medical device company specializing in minimally-invasive surgical tools for spinal and musculoskeletal procedures. The company generated $1.6B in revenue in FY 2025, positioning it as a scaled player in the orthopedic device market.
Profile data last refreshed 15h ago · AI intelligence enriched 1mo ago
Hot — 1032 jobs added in 30d
Net +925 (1032 new, 107 removed). Aggressive expansion phase.
Best suited for device engineers, commercial professionals, and clinical ops roles; less attractive for traditional pharma scientists or drug developers.
Help build intelligence for Globus Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Globus Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now - TradingView
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now TradingView
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally? - TradingView
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally? TradingView
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - TradingView
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms TradingView
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - TradingView
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now TradingView
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - TradingView
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y TradingView
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain WAT Stock in Your Portfolio for Now TradingView
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Safety of Transcranial Motor-Evoked Potential Linked Quadripolar Montage.
Biomechanical comparison of triangular osteosynthesis and triangular minimally invasive spinopelvic stabilization technique for pelvic fragility fractures.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo